ياهلا بوابة السفر والسياحة
Abbott, a global healthcare leader, announced the launch of its latest generation of continuous glucose monitoring (CGM) technology, FreeStyle Libre 3 Plus*, in the Kingdom of Saudi Arabia.
The launch comes at a critical time as Saudi Arabia continues to face one of the world’s highest diabetes prevalence rates, with more than 5 million adults – nearly 1 in 4 – living with the condition. Libre CGM systems help people living with diabetes better understand how different foods, exercise and medications impact their glucose levels in real time, enabling them to make more informed decisions on how they can manage their diabetes on their own terms.
Designed to make glucose monitoring simpler and more user-friendly, FreeStyle Libre 3 Plus* empowers individuals to take an active role in living with their condition, increasing confidence and driving better health outcomes. The FreeStyle Libre 3 Plus sensor is Abbott’s smallest sensor to date‡, developed with user’s everyday needs in mind. The sensor is discreet, easy to apply, and offers an extended wear of up to 15 days — requiring only six sensors every three months — while providing outstanding accuracy with real-time glucose readings sent directly to FreeStyle Libre 3 users’ smartphone app#.
The system is approved for all people with diabetes aged 2 and older, including pregnant women, reinforcing Abbott’s commitment to helping people access the care they need and live healthier, fuller lives.
‘As the global leader in CGM, Abbott continues to advance the standard of diabetes care and make it easier for people to manage their condition,’ said Mohammad Househ, general manager of Abbott’s diabetes care business in Saudi Arabia, Bahrain, the Middle East and Northern Africa. ‘We are proud to introduce in Saudi Arabia FreeStyle Libre 3 Plus*, our most compact and user-friendly sensor yet, offering transformative benefits to help people living with diabetes take actions that can add up to big changes over time.’
